Adicet Bio, Inc.
ACET
$6.47
-$0.26-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -116.80M | -115.01M | -118.64M | -117.32M | -117.12M |
| Total Depreciation and Amortization | 6.38M | 6.53M | 6.55M | 6.50M | 6.47M |
| Total Amortization of Deferred Charges | 43.00K | 15.00K | 15.00K | 15.00K | 39.00K |
| Total Other Non-Cash Items | 13.66M | 11.40M | 16.20M | 20.12M | 23.76M |
| Change in Net Operating Assets | 1.47M | -1.37M | -2.26M | -4.24M | -5.53M |
| Cash from Operations | -95.25M | -98.44M | -98.14M | -94.93M | -92.38M |
| Capital Expenditure | -1.74M | -1.92M | -2.12M | -2.37M | -1.12M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.13M | 26.73M | -86.49M | -119.49M | -118.12M |
| Cash from Investing | 2.39M | 24.81M | -88.61M | -121.86M | -119.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -- | -- | -- |
| Issuance of Common Stock | 75.50M | 404.00K | 404.00K | 341.00K | 111.45M |
| Repurchase of Common Stock | -104.00K | -104.00K | -104.00K | -104.00K | -141.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 75.25M | 150.00K | 300.00K | 237.00K | 111.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.61M | -73.48M | -186.45M | -216.55M | -100.31M |